NCT06776458View on ClinicalTrials.gov

Chronic Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer

RecruitingOBSERVATIONAL

Enrollment

112

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Breast Cancer Females

Interventions

OTHER

N/A - Usual Care

Breast cancer survivors will have received usual care aromatase inhibitors for up to 10 years post-diagnosis.

Trial Locations (1)

M5S2C9

RECRUITING

University of Toronto, Toronto

Sponsors

Collaborators (1)

Cancer Research Society

All Listed Sponsors

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Cancer Research Society

OTHER

lead

University of Toronto

OTHER

NCT06776458 - Chronic Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer | Biotech Hunter | Biotech Hunter